These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38767019)

  • 1. Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens.
    Aydin-Ghormoz E; Ortiz J; Koizumi N; Li MH; Faddoul G
    Pediatr Transplant; 2024 Jun; 28(4):e14783. PubMed ID: 38767019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States.
    Riad S; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2021 Aug; 25(5):e13928. PubMed ID: 33314638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate.
    Tanriover B; Jaikaransingh V; MacConmara MP; Parekh JR; Levea SL; Ariyamuthu VK; Zhang S; Gao A; Ayvaci MUS; Sandikci B; Rajora N; Ahmed V; Lu CY; Mohan S; Vazquez MA
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1650-1661. PubMed ID: 27364616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
    Riad S; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation.
    Puliyanda DP; Pizzo H; Rodig N; Somers MJG
    Pediatr Transplant; 2020 May; 24(3):e13685. PubMed ID: 32112514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
    Sureshkumar KK; Hussain SM; Nashar K; Marcus RJ
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):741-9. PubMed ID: 24969182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of kidney allograft outcomes in steroid use versus steroid discontinuation after basiliximab and ATG induction: A UNOS database study.
    Nissaisorakarn P; Patel H; Cardarelli F; Amtul A
    Clin Nephrol; 2024 Jul; 102():39-50. PubMed ID: 38699983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
    Aydin-Ghormoz EA; Perlmutter J; Koizumi N; Ortiz J; Faddoul G
    Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
    Zang S; Zhang X; Niu J; Das BB
    Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
    Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
    Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
    Sampaio MS; Chopra B; Sureshkumar KK
    Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome.
    Kesiraju S; Paritala P; Rao Ch UM; Athmakuri SM; Reddy VS; Sahariah S
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
    Umber A; Killackey M; Paramesh A; Liu Y; Qin H; Atiq M; Lee B; Alper AB; Simon E; Buell J; Zhang R
    J Nephrol; 2017 Apr; 30(2):289-295. PubMed ID: 27062485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
    Taber DJ; McGillicuddy JW; Bratton CF; Rohan VS; Nadig S; Dubay D; Baliga PK
    Ann Surg; 2017 Sep; 266(3):450-456. PubMed ID: 28654544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
    Custodio LFP; Martins SBS; Viana LA; Cristelli MP; Requião-Moura L; Chow CYZ; Camargo SFDN; Nakamura MR; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Pediatr Transplant; 2024 May; 28(3):e14713. PubMed ID: 38553819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long-term longitudinal follow-up.
    Jain A; Daoud D; Kees-Folts D; Freeman MA; Butt F; Abendroth CS; Shike H; Kadry Z
    Pediatr Transplant; 2022 Mar; 26(2):e14173. PubMed ID: 34687570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
    Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
    Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.